Chemomab Therapeutics (CMMB) Institutional Ownership $2.14 +0.19 (+9.74%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Chemomab Therapeutics (NASDAQ:CMMB)CurrentInstitutional OwnershipPercentage46.05%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.91MNumber ofInstitutional Sellers(last 12 months)0 Get CMMB Insider Trade Alerts Want to know when executives and insiders are buying or selling Chemomab Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CMMB Institutional Buying and Selling by Quarter Chemomab Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024Sphera Funds Management LTD.1,214,575$1.91M0.3%N/A8.458% 2/1/2023Kestra Private Wealth Services LLC31,241$100K0.0%N/A0.271% 2/14/2022GSA Capital Partners LLP11,277$78K0.0%N/A0.099% 1/28/2022ARK Investment Management LLC267,292$1.84M0.0%+48.1%2.344% 11/17/2021Yahav Achim Ve Achayot Provident Funds Management Co Ltd.3,097$34K0.0%N/A0.027% 11/5/2021Advisor Group Holdings Inc.54,821$608K0.0%N/A0.481% 11/3/2021Meitav Dash Investments Ltd.37,567$416K0.0%-7.6%0.330% 9/17/2021Virtu Financial LLC13,180$251K0.0%N/A0.116% 8/25/2021Marshall Wace LLP63,554$1.21M0.0%N/A0.558% 8/25/2021Marshall Wace North America L.P.44,035$837K0.0%N/A0.386% 8/18/2021Ikarian Capital LLC290,534$5.53M0.4%N/A2.640% 8/18/2021Meitav Dash Investments Ltd.40,664$773K0.0%+389.3%0.370% 8/17/2021Boothbay Fund Management LLC54,729$1.04M0.0%-11.4%0.512% 8/16/2021Marshall Wace LLP63,554$1.21M0.0%N/A0.594% 8/5/2021Meitav Dash Investments Ltd.40,664$773K0.0%+389.3%0.380% 5/18/2021Orbimed Advisors LLC2,578,174$74.02M0.7%N/A110.320% 5/13/2021Renaissance Technologies LLC7,023$202K0.0%N/A0.301% 5/6/2021Meitav Dash Investments Ltd.8,311$239K0.0%N/A0.356% (Data available from 1/1/2016 forward) CMMB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CMMB shares? During the previous two years, the following institutional investors and hedge funds held shares of Chemomab Therapeutics shares: Sphera Funds Management LTD. ($1.91M), Kestra Private Wealth Services LLC ($100K).Learn more on CMMB's institutional investors. What percentage of Chemomab Therapeutics stock is owned by institutional investors? 46.05% of Chemomab Therapeutics stock is owned by institutional investors. Learn more on CMMB's institutional investor holdings. Which institutional investors have been buying Chemomab Therapeutics stock? The following institutional investors have purchased Chemomab Therapeutics stock in the last 24 months: Sphera Funds Management LTD. ($1.21M), and Kestra Private Wealth Services LLC ($31.24K). How much institutional buying is happening at Chemomab Therapeutics? Institutional investors have bought a total of 1,245,816 shares in the last 24 months. This purchase volume represents approximately $2.01M in transactions. Related Companies NVCT Institutional Ownership DBVT Institutional Ownership INZY Institutional Ownership TARA Institutional Ownership MGX Institutional Ownership ELUT Institutional Ownership ENTA Institutional Ownership IGMS Institutional Ownership CABA Institutional Ownership MIST Institutional Ownership This page (NASDAQ:CMMB) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemomab Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemomab Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CMMB Stock Alerts